{"id":"https://openalex.org/W7208813890","doi":"https://doi.org/10.5281/zenodo.22279294","title":"Immune Checkpoint Inhibitor-Induced Myocarditis in a Patient with Metastatic Melanoma: A Case Report","display_name":"Immune Checkpoint Inhibitor-Induced Myocarditis in a Patient with Metastatic Melanoma: A Case Report","alternate_titles":[],"publication_year":2025,"publication_date":"2025-05-15","ids":{"openalex":"https://openalex.org/W7208813890","doi":"https://doi.org/10.5281/zenodo.22279294"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.22279294","doi":"https://doi.org/10.5281/zenodo.22279294","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.22279294","pdf_url":null,"source":{"id":"https://openalex.org/S4393919083","display_name":"Archives of clinical case reports","issn_l":"2688-1071","issn":["2688-1071"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"parent_works":[],"lineage":["https://openalex.org/W7208813890"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.5281/zenodo.22279294","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5150082101","display_name":"Fitzgerald C","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fitzgerald C","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5150336906","display_name":"Lombardi C","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lombardi C","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5150087676","display_name":"Boer JD","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Boer JD","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11112","display_name":"Viral Infections and Immunology Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11638","display_name":"Cardiac tumors and thrombi","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-induced-myocarditis","display_name":"immune checkpoint inhibitor-induced myocarditis","score":0.8949999809265137},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.8529999852180481},{"id":"https://openalex.org/keywords/ctla-4-inhibitors","display_name":"CTLA-4 inhibitors","score":0.8939999938011169},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.8930000066757202},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.996999979019165},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.7400000095367432},{"id":"https://openalex.org/keywords/conduction-abnormalities","display_name":"conduction abnormalities","score":0.7089999914169312},{"id":"https://openalex.org/keywords/cardiogenic-shock","display_name":"cardiogenic shock","score":0.9869999885559082},{"id":"https://openalex.org/keywords/inflammatory-myopathies","display_name":"myositis","score":0.8069999814033508},{"id":"https://openalex.org/keywords/ruxolitinib","display_name":"ruxolitinib","score":0.8569999933242798},{"id":"https://openalex.org/keywords/abatacept","display_name":"abatacept","score":0.8199999928474426},{"id":"https://openalex.org/keywords/antithymocyte-globulin","display_name":"antithymocyte globulin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.8569999933242798},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.47200000286102295}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8528000116348267},{"id":"https://openalex.org/C2781107259","wikidata":"https://www.wikidata.org/wiki/Q5508364","display_name":"Fulminant","level":2,"score":0.7662000060081482},{"id":"https://openalex.org/C2776850375","wikidata":"https://www.wikidata.org/wiki/Q2477062","display_name":"Cardiogenic shock","level":3,"score":0.6175000071525574},{"id":"https://openalex.org/C2780875844","wikidata":"https://www.wikidata.org/wiki/Q186235","display_name":"Myocarditis","level":2,"score":0.597000002861023},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.5300999879837036},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.49709999561309814},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.474700003862381},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.4587000012397766},{"id":"https://openalex.org/C187316915","wikidata":"https://www.wikidata.org/wiki/Q92307203","display_name":"Case fatality rate","level":3,"score":0.4512999951839447},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.4489000141620636},{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.42890000343322754},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.37720000743865967},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.37619999051094055},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.3686000108718872},{"id":"https://openalex.org/C3020000205","wikidata":"https://www.wikidata.org/wiki/Q2412849","display_name":"Narrative review","level":2,"score":0.3483000099658966},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.33959999680519104},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3379000127315521},{"id":"https://openalex.org/C2910239545","wikidata":"https://www.wikidata.org/wiki/Q3843811","display_name":"Immune Dysfunction","level":3,"score":0.33329999446868896},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.31949999928474426},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3179999887943268},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31690001487731934},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.29350000619888306},{"id":"https://openalex.org/C2778650287","wikidata":"https://www.wikidata.org/wiki/Q7838098","display_name":"Tremelimumab","level":5,"score":0.28139999508857727},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.27129998803138733}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.22279294","doi":"https://doi.org/10.5281/zenodo.22279294","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.22279294","pdf_url":null,"source":{"id":"https://openalex.org/S4393919083","display_name":"Archives of clinical case reports","issn_l":"2688-1071","issn":["2688-1071"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.5281/zenodo.22279295","doi":"https://doi.org/10.5281/zenodo.22279295","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.22279295","pdf_url":null,"source":{"id":"https://openalex.org/S4393919083","display_name":"Archives of clinical case reports","issn_l":"2688-1071","issn":["2688-1071"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.5281/zenodo.22279294","doi":"https://doi.org/10.5281/zenodo.22279294","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.22279294","pdf_url":null,"source":{"id":"https://openalex.org/S4393919083","display_name":"Archives of clinical case reports","issn_l":"2688-1071","issn":["2688-1071"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4387276459","https://openalex.org/W3187591556","https://openalex.org/W4390732765","https://openalex.org/W4294147855","https://openalex.org/W7143403064","https://openalex.org/W3010985805","https://openalex.org/W7167424637","https://openalex.org/W2915111813","https://openalex.org/W3015584262","https://openalex.org/W4412805676"],"abstract_inverted_index":{"Background:":[0],"Immune":[1],"checkpoint":[2],"inhibitors":[3],"(ICIs)":[4],"targeting":[5],"CTLA-4,":[6],"PD-1":[7],"and":[8,15,39,96,111,121,144],"PD-L1":[9],"have":[10,114],"transformed":[11],"treatment":[12],"of":[13,55,76,93,146],"metastaticmelanoma":[14],"other":[16],"cancers,":[17],"but":[18],"the":[19,29,33,49,123],"same":[20],"mechanism":[21],"that":[22],"unleashes":[23],"anti-tumour":[24],"immunity":[25],"can":[26],"also":[27],"attack":[28],"myocardium.Objective:":[30],"To":[31],"review":[32,54],"published":[34,135],"case":[35,56,58],"reports,":[36,57],"series,":[37,59],"registries":[38],"mechanistic":[40,64],"literature":[41,50],"on":[42],"ICI":[43,142],"myocarditis,":[44],"drawing":[45],"onmelanoma-specific":[46],"reports":[47],"where":[48],"specifies":[51],"them.Methods:":[52],"Narrative":[53],"pharmacovigilance":[60],"analyses,":[61],"registry":[62,92],"cohorts,":[63],"studies":[65],"andguideline":[66],"documents.Findings:":[67],"Reported":[68],"incidence":[69],"ranges":[70],"from":[71],"roughly":[72],"0.06%":[73],"to":[74,130],"1.3%":[75],"ICI-treated":[77],"patients,":[78],"rising":[79],"toward":[80],"2%":[81],"with":[82,106,117,151],"combinationtherapy.":[83],"Onset":[84],"is":[85],"typically":[86],"early":[87,138],"(median":[88],"34":[89],"days,":[90],"one":[91,128],"35":[94],"patients),":[95],"historical":[97],"fatality":[98,132],"has":[99],"reached":[100],"25-50%.Published":[101],"cases":[102],"document":[103],"fulminant":[104],"presentations":[105],"conduction":[107],"abnormalities,":[108],"cardiogenic":[109],"shock":[110],"myositis;":[112],"refractorycases":[113],"been":[115],"treated":[116],"anti-thymocyte":[118],"globulin,":[119],"abatacept":[120],"ruxolitinib,":[122],"latter":[124],"combination":[125],"linked":[126],"in":[127,148],"cohort":[129],"amarked":[131],"reduction.Conclusions:":[133],"The":[134],"record":[136],"supports":[137],"biomarker-based":[139],"suspicion,":[140],"prompt":[141],"discontinuation,":[143],"stepwiseescalation":[145],"immunosuppression":[147],"refractory":[149],"disease,":[150],"still-limited":[152],"evidence":[153],"for":[154],"targeted":[155],"second-line":[156],"agents":[157]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7208813890","counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2026-09-06T00:00:00"}
